M. Tomikawa et al., CHEMOSENSITIVITY OF HUMAN PANCREATIC-CANCER CELL-LINES SERIALLY TRANSPLANTED IN NUDE-MOUSE, Anticancer research, 18(2A), 1998, pp. 1059-1062
Background: Pancreatic cancer frequently recurs or metastasizes even a
fter apparently curative surgical resection. Because of a low, five-ye
ar, survival rate after radical surgery multi-modal adjuvant treatment
must be used to prevent recurrence of systemic spread Materials and M
ethods: The effectiveness of the experimental cancer chemotherapy of m
itomycin C (MMC), cisplatin (DDP), doxorubicin (DXR) and 5-fluorouraci
l (5-FU) was evaluated in three human pancreatic cancer xenografts ser
ially transplanted in nude mice. Results: When the effects of these ag
ents were evaluated by 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tet
razolium bromide (MTT) assay, only MMC and DDP were effecffve on PAN-3
-JCK, a poorly differentiated adenocarcinoma. When PAN-12-JCK a modera
tely differentiated adenocarcinoma, was used an in vivo assessment of
combined chemotherapy of MMC and DDP, a synergistic combination effect
was observed. Three xenografts were transplanted subcutaneously into
nude mice and the maximum tolerated doses of these agents were adminis
tered intraperitoneally or intravenously (DXR). MMC showed positive an
titumor activity on PAN-3-JCK and PAN-12-JCK and 5-FU was effective on
PAN-12-JCK. Conclusions: These results reflect the low sensitivity of
clinical pancreatic cancer to conventionally available antitumor agen
ts, and suggest the possible synergistic combination antitumor activit
y of MMC and DDP.